BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8331781)

  • 1. [Cardiac contractile proteins].
    Sugiura S; Sata M; Serizawa T
    Nihon Rinsho; 1993 May; 51(5):1146-50. PubMed ID: 8331781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of myosin mutations that cause familial hypertrophic cardiomyopathy.
    Roopnarine O; Leinwand LA
    Biophys J; 1998 Dec; 75(6):3023-30. PubMed ID: 9826622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication.
    Fujita H; Sugiura S; Momomura S; Omata M; Sugi H; Sutoh K
    J Clin Invest; 1997 Mar; 99(5):1010-5. PubMed ID: 9062359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of actin, myosin, and an actin-binding protein of chronic myelogenous leukemia leukocytes.
    Boxer LA; Stossel TP
    J Clin Invest; 1976 Apr; 57(4):964-76. PubMed ID: 133121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myosin mutations in hypertrophic cardiomyopathy and functional implications.
    Vosberg HP
    Herz; 1994 Apr; 19(2):75-83. PubMed ID: 8194835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The advances of research for cardiac contractile proteins structure and function].
    Wei L; Wang L; Wang Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Sep; 14(3):299-308. PubMed ID: 11326855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.
    Eldin P; Le Cunff M; Mornet D; Leger JJ
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):345-51. PubMed ID: 7887887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast myosin II: a new subclass of unconventional conventional myosins?
    May KM; Win TZ; Hyams JS
    Cell Motil Cytoskeleton; 1998; 39(3):195-200. PubMed ID: 9519900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characterization of the function of myosin loop 4 in the actin-myosin interaction.
    Gyimesi M; Tsaturyan AK; Kellermayer MS; Málnási-Csizmadia A
    Biochemistry; 2008 Jan; 47(1):283-91. PubMed ID: 18067324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle myosin II structure and function.
    Lutz GJ; Lieber RL
    Exerc Sport Sci Rev; 1999; 27():63-77. PubMed ID: 10791014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of the N-terminal fragment of myosin regulatory light chain for myosin-actin interaction.
    Stepkowski D; Szczesna D; Babiychuk EB; Borovikov YS; Kakol I
    Biochem Mol Biol Int; 1995 Mar; 35(3):677-84. PubMed ID: 7773203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative rigor binding of myosin to actin is a function of F-actin structure.
    Orlova A; Egelman EH
    J Mol Biol; 1997 Feb; 265(5):469-74. PubMed ID: 9048941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternative domain near the nucleotide-binding site of Drosophila muscle myosin affects ATPase kinetics.
    Miller BM; Zhang S; Suggs JA; Swank DM; Littlefield KP; Knowles AF; Bernstein SI
    J Mol Biol; 2005 Oct; 353(1):14-25. PubMed ID: 16154586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N-terminal domain of MYO18A has an ATP-insensitive actin-binding site.
    Isogawa Y; Kon T; Inoue T; Ohkura R; Yamakawa H; Ohara O; Sutoh K
    Biochemistry; 2005 Apr; 44(16):6190-6. PubMed ID: 15835906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for the higher Ca(2+)-activation of the regulated actin-activated myosin ATPase observed with Dictyostelium/Tetrahymena actin chimeras.
    Matsuura Y; Stewart M; Kawamoto M; Kamiya N; Saeki K; Yasunaga T; Wakabayashi T
    J Mol Biol; 2000 Feb; 296(2):579-95. PubMed ID: 10669610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A missense mutation of cardiac beta-myosin heavy chain gene linked to familial hypertrophic cardiomyopathy in affected Japanese families.
    Harada H; Kimura A; Nishi H; Sasazuki T; Toshima H
    Biochem Biophys Res Commun; 1993 Jul; 194(2):791-8. PubMed ID: 8343162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypically selected mutations in myosin's actin binding domain demonstrate intermolecular contacts important for motor function.
    Giese KC; Spudich JA
    Biochemistry; 1997 Jul; 36(28):8465-73. PubMed ID: 9214290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-induced quenching of intrinsic fluorescence in brain myosin V is linked to dissociation of calmodulin light chains.
    Cameron LC; Carvalho RN; Araujo JR; Santos AC; Tauhata SB; Larson RE; Sorenson MM
    Arch Biochem Biophys; 1998 Jul; 355(1):35-42. PubMed ID: 9647664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of atrial myosin light chains in modulating the functional properties of myocardium].
    Khalina IaN; Shpagina MD; Malyshev SL; Podlubnaia ZA
    Biofizika; 2003; 48(5):900-4. PubMed ID: 14582417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome.
    Sata M; Ikebe M
    J Clin Invest; 1996 Dec; 98(12):2866-73. PubMed ID: 8981935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.